These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10461652)

  • 1. Soluble ICAM-1 seems to be related to prognosis in malignant melanoma.
    Wollina U; Karte K; Hipler UC; Olbertz K
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):264-6. PubMed ID: 10461652
    [No Abstract]   [Full Text] [Related]  

  • 2. Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions.
    Ciotti P; Pesce GP; Cafiero F; Rainero ML; Sementa A; Nicolò G; Mela GS; Bagnasco M; Santi PL; Bianchi-Scarrà G
    Melanoma Res; 1999 Jun; 9(3):253-60. PubMed ID: 10465581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
    Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
    Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of expression and soluble form of intercellular adhesion molecule-1 in malignant melanoma.
    Kageshita T; Yoshii A; Kimura T; Ono T
    J Dermatol; 1992 Nov; 19(11):836-40. PubMed ID: 1284075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma.
    Miller JG; Gee J; Price A; Garbe C; Wagner M; Mac Neil S
    Melanoma Res; 1997 Jun; 7(3):197-208. PubMed ID: 9195558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis.
    Krisp C; Parker R; Pascovici D; Hayward NK; Wilmott JS; Thompson JF; Mann GJ; Long GV; Scolyer RA; Molloy MP
    Br J Cancer; 2018 Sep; 119(6):713-723. PubMed ID: 30116025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma: an androgen-dependent tumour?
    Rampen FH; Mulder JH
    Lancet; 1980 Mar; 1(8168 Pt 1):562-4. PubMed ID: 6102285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma.
    Oba J; Nakahara T; Hayashida S; Kido M; Xie L; Takahara M; Uchi H; Miyazaki S; Abe T; Hagihara A; Moroi Y; Furue M
    J Am Acad Dermatol; 2011 Dec; 65(6):1152-60. PubMed ID: 21700362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathology of malignant melanoma.
    Heasley DD; Toda S; Mihm MC
    Surg Clin North Am; 1996 Dec; 76(6):1223-55. PubMed ID: 8977548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Gadiot J; Hooijkaas AI; Kaiser AD; van Tinteren H; van Boven H; Blank C
    Cancer; 2011 May; 117(10):2192-201. PubMed ID: 21523733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a melanoma cell line with metastatic characteristics.
    Enjoji M; Nakashima M; Sakai H; Nawata H
    Hum Cell; 1995 Sep; 8(3):115-20. PubMed ID: 8652447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C in primary malignant melanoma of the skin.
    Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S
    Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics analysis of binding between melanoma cells and neutrophils.
    Hoskins MH; Dong C
    Mol Cell Biomech; 2006 Jun; 3(2):79-87. PubMed ID: 16903259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in shedding of intercellular adhesion molecule-1 in human malignant melanoma cell lines treated with hyperthermia in vitro.
    Nakayama J; Kageshita T; Nakashima M; Tsujisaki M; Imai K; Hori Y
    Pigment Cell Res; 1996 Jun; 9(3):154-8. PubMed ID: 8888315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage I cutaneous melanoma. Clinical and epidemiological findings on 313 cases].
    Reali UM; Bondi R; Giannotti B
    G Ital Dermatol Venereol; 1987 Dec; 122(12):609-17. PubMed ID: 3447992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation between the degree of histological progression (according to Clark and Breslow) and prognosis in cases of malignant melanoma stage I (T1-3, No, Mo)].
    Kwiatkowska W; Dabska M
    Nowotwory; 1983; 33(2):149-52. PubMed ID: 6664885
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical management of cutaneous melanoma: current practice and impact on prognosis.
    Mosca PJ; Tyler DS; Seigler HF
    Adv Surg; 2004; 38():85-119. PubMed ID: 15515616
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual variants of malignant melanoma.
    Barnhill RL; Gupta K
    Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
    Guo H; Cheng Y; Martinka M; McElwee K
    Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.